Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine Administration for Preterms: Pharmacokinetics, Utilization and Correlation Inhibiting Nociception Outcome
2025-523475-33-00Phase 4Authorised
- Sponsor
- Masaryk University
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of caffeine in apnea of prematurity (AOP) (2 arms), sponsored by Masaryk University. Planned start Feb 2026; status: authorised.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on 2025-523475-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523475-33-00.